Medifron DBT Co., Ltd. announced private placement of 3,333,333 shares at a price of KRW 1,500 per share for gross proceeds of KRW 4,999,999,500 with returning investor T Scientific Co., Ltd. on June 22, 2022. The securities issued are subject to hold period of 1 year. The expected payment date is September 30, 2022.

The transaction is approved by the board of directors of the company.